Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amerise Biosciences has informed the BSE that its insider trading window will be closed starting Wednesday, 1st October 2025. The closure will remain in effect until 48 hours after the company announces its unaudited financial results for the quarter ended 30th September 2025 (Q2 FY26). This is a routine compliance step taken under SEBI's insider trading regulations to prevent trading by insiders during the quiet period before results are disclosed. The exact date of the board meeting to approve the quarterly numbers has not yet been announced and will be communicated later. The intimation has been signed by Director Dinesh Rathod.
This is a routine regulatory disclosure with no direct impact on shareholders or the stock price. However, it signals that the company's Q2 FY26 earnings announcement is likely within the next few weeks, which investors should watch for as it could influence trading sentiment in the stock.